Centrally-acting non-narcotic antitussive, chemically related to codeine but devoid of central depressant effects (AEMPS 2014, Ida 1997).Chemically similar to dextromethorphan (Shin 2011).Administered orally 3 times a day.A product which has very few bibliographical references. Since the last update, we have not found published data on its excretion in breast milk. Its use is authorized in infants from 6 months of age. Given its lack of sedative effects, use at a sufficient minimum dose and for non-prolonged periods would have low risk during breastfeeding. As there is less published experience than with other drugs from the same group, safer known alternatives may be preferable during the neonatal period and in case of prematurity.